Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -34.90% | -29.00% | -20.79% | -- |
| Total Receivables | -- | -94.58% | -- | 199.43% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 165.60% | -- | -44.11% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -1.85% | -- |
| Total Current Assets | -- | -32.91% | -- | -20.88% | -- |
|
|
|||||
| Total Current Assets | -- | -32.91% | -- | -20.88% | -- |
| Net Property, Plant & Equipment | -- | 7.90% | -- | -10.54% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -15.79% | -- | -14.52% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -53.13% | -- | 37.50% | -- |
| Total Assets | -- | -31.39% | -- | -20.48% | -- |
|
|
|||||
| Total Accounts Payable | -- | -59.76% | -- | -84.52% | -- |
| Total Accrued Expenses | -- | 151.20% | -- | -20.32% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 38.89% | -- | -45.96% | -- |
| Total Finance Division Other Current Liabilities | -- | -68.03% | -- | -96.90% | -- |
| Total Other Current Liabilities | -- | -68.03% | -- | -96.90% | -- |
| Total Current Liabilities | -- | 11.61% | -- | -66.54% | -- |
|
|
|||||
| Total Current Liabilities | -- | 11.61% | -- | -66.54% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 612.33% | -- | -86.67% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -69.04% | -- | 56.05% | -- |
| Total Liabilities | -- | 12.80% | -- | -64.77% | -- |
|
|
|||||
| Common Stock & APIC | -- | -29.81% | -- | 1.61% | -- |
| Retained Earnings | -- | 30.69% | -- | -4.74% | -- |
| Treasury Stock & Other | -- | -111.70% | -- | -55.39% | -- |
| Total Common Equity | -- | -35.42% | -18.32% | -9.19% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -- | -35.42% | -18.32% | -9.19% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -- | -35.42% | -18.32% | -9.19% | -- |
|
|
|||||